In an attempt to discover anti-HIV agents with much reduced cytotoxicity from the currently available HIV-reverse transcriptase inhibitors, AZT conjugates of cholanic acids, 2-imidazolidone-4- carboxylic acid and its derivatives, and N, N'-disubstituted 5-hydroxy-tetrahydropyrimidin-2-ones have been synthesized and their anti-HIV profiles determined with CEM-SS cell line. The AZT conjugates with 2-imidazolidone-4- carboxylic acid and 2-pyrrolidone-5-carboxylic acid through an ester linkage, and with N,N'-diphenyl-5-hydroxy-tetrahydropyrimidin-2-one through a succinate tether showed significantly higher therapeutic indexes than AZT while they also retained or enhanced AZT's anti-HIV activity. Thus, structural features that favor the desired therapeutic profile of the conjugates appear to include a five-membered ring cyclic urea or lactam, and six-membered ring cyclic urea with N,N'-diphenyl substitution.
In an attempt to discover anti-HIV agents with much reduced cytotoxicity from the currently available HIV-reverse transcriptase inhibitors, AZT conjugates of cholanic acids, 2-imidazolidone-4- carboxylic acid and its derivatives, and N, N'-disubstituted 5-hydroxy-tetrahydropyrimidin-2-ones have been synthesized and their anti-HIV profiles determined with CEM-SS cell line. The AZT conjugates with 2-imidazolidone-4- carboxylic acid and 2-pyrrolidone-5-carboxylic acid through an ester linkage, and with N,N'-diphenyl-5-hydroxy-tetrahydropyrimidin-2-one through a succinate tether showed significantly higher therapeutic indexes than AZT while they also retained or enhanced AZT's anti-HIV activity. Thus, structural features that favor the desired therapeutic profile of the conjugates appear to include a five-membered ring cyclic urea or lactam, and six-membered ring cyclic urea with N,N'-diphenyl substitution.
Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
申请人:UNILEVER PLC
公开号:EP0446047A1
公开(公告)日:1991-09-11
The invention relates to pharmaceutical and cosmetic compositions comprising at least one benzisothiazolinone-1-dioxide derivative with the formula:
where R¹ can be hydrogen, and R² can be certain generally hydrophobic C₈-C₂₀ aliphatic groups or the group:
where R⁵ is aliphatic or else R² is a saturated or unsaturated C₂-C₆ group ending in an aromatic nucleus.
These compositions can be used to inhibit elastases such as human leucocytic elastase. They may be applied topically as a cosmetic.
Many of the benzisothiazolinone-1-dioxide derivative specified as active ingredient in such compositions are novel compounds.
Stable denaturants for use in electrophoretic techniques and methods of using the same
申请人:FMC CORPORATION
公开号:EP0809103A2
公开(公告)日:1997-11-26
This invention presents, inter alia, a class of high power denaturants that are stable in aqueous environments and can be used in electrophoretic techniques such as DNA sequencing and related techniques. The denaturants and electrophoretic media of the invention provide a basis for the high resolution analysis of biological molecules. The denaturants of the invention are also believed to be suitable for electrophoresis of DNA, RNA, proteins, and other macromolecules.
本发明特别提出了一类在水环境中稳定的高能变性剂,可用于 DNA 测序等电泳技术及相关技术。本发明的变性剂和电泳介质为生物分子的高分辨率分析提供了基础。据信,本发明的变性剂也适用于 DNA、RNA、蛋白质和其他大分子的电泳。
Synthetic electroorganic chemistry. 14. Synthesis of 5-fluorouracil derivatives having N-acylazacycloalkanes and lactams